Evidence map›Paper›PMID 27428993›Full record

ReviewViruses2016

RNA Encapsidation and Packaging in the Phleboviruses.

Katherine E Hornak, Jean-Marc Lanchy, J Stephen Lodmell

Open access · goldAbstract readReview
In one paragraph

Review in Viruses, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 40 citations in OpenAlex.

  1. Virulence · 2025
    Review
  2. Article
  3. Review
  4. The public health threat of emerging phenuiviruses.One health (Amsterdam, Netherlands) · 2025
    Review
  5. Review
  6. Article
  7. The Phlebovirus Ribonucleoprotein: An Overview.Methods in molecular biology (Clifton, N.J.) · 2024
    Review
  8. Article
  9. ICTV Virus Taxonomy Profile:The Journal of general virology · 2023
    Article
  10. Viral Replicon Systems and Their Biosafety Aspects.Applied biosafety : journal of the American Biological Safety Association · 2023
    Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Katherine E HornakDivision of Biological Sciences, University of Montana, Missoula, MT 59812, USA. katherine.hornak@umontana.edu.
Jean-Marc LanchyDivision of Biological Sciences, University of Montana, Missoula, MT 59812, USA. jean-marc.lanchy@umontana.edu.
J Stephen LodmellDivision of Biological Sciences, University of Montana, Missoula, MT 59812, USA. stephen.lodmell@umontana.edu.
University of Montana · US

Funding

Surveillance genome sequencing to detect SARS-CoV-2 virus variants in MontanaP20GM103546 · NIGMS · UNIVERSITY OF MONTANA · PI BOWLER, BRUCE E · 2012 to 2021
$19.2M
Mechanism of RVFV nucleocapsid targeting drugsR15AI105737 · NIAID · UNIVERSITY OF MONTANA · PI LODMELL, J. STEPHEN · 2014 to 2014
$432k
NIAID NIH HHS R15 AI105737NIGMS NIH HHS P20 GM103546
6 · The paper itself

Abstract

The Bunyaviridae represents the largest family of segmented RNA viruses, which infect a staggering diversity of plants, animals, and insects. Within the family Bunyaviridae, the Phlebovirus genus includes several important human and animal pathogens, including Rift Valley fever virus (RVFV), severe fever with thrombocytopenia syndrome virus (SFTSV), Uukuniemi virus (UUKV), and the sandfly fever viruses. The phleboviruses have small tripartite RNA genomes that encode a repertoire of 5-7 proteins. These few proteins accomplish the daunting task of recognizing and specifically packaging a tri-segment complement of viral genomic RNA in the midst of an abundance of host components. The critical nucleation events that eventually lead to virion production begin early on in the host cytoplasm as the first strands of nascent viral RNA (vRNA) are synthesized. The interaction between the vRNA and the viral nucleocapsid (N) protein effectively protects and masks the RNA from the host, and also forms the ribonucleoprotein (RNP) architecture that mediates downstream interactions and drives virion formation. Although the mechanism by which all three genomic counterparts are selectively co-packaged is not completely understood, we are beginning to understand the hierarchy of interactions that begins with N-RNA packaging and culminates in RNP packaging into new virus particles. In this review we focus on recent progress that highlights the molecular basis of RNA genome packaging in the phleboviruses.

Indexed as

Virus AssemblyAnimalsHumansInsectaNucleocapsid ProteinsPhlebovirusPlantsRNA, ViralNucleocapsid ProteinsRNA, ViralbunyavirusphlebovirusRNA packaging

Identifiers

PMID27428993
PMCPMC4974529
OpenAlexW2463105528

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.